InvestorsHub Logo
Followers 34
Posts 2484
Boards Moderated 0
Alias Born 02/04/2013

Re: nidan7500 post# 448720

Monday, 01/22/2024 9:35:24 AM

Monday, January 22, 2024 9:35:24 AM

Post# of 461360
Here is my question to Dr. Missling and the board. How come we shareholders don’t know what stage of the process we are in for Rett or Alzheimer’s? Meaning after the pediatric results are we going for approval in all countries that we did the trials? If not why not. If so why not state that it is our intention based on the totality of the data we will seek approval from all agencies within the next quarter. Or something to that effect. Yes they stated that they are going for approval from EMA but can anyone for certain say where we are in the process? We are in the dark still after all this time. Are we closer to approval or do we need to do more trials? I used to think that the company was quite for strategic reasons but now I just don’t know. Where is the FDA guidance. Alzheimer’s has been completed for over a year now. Nothing from the FDA?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News